{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:29:58Z","timestamp":1778599798768,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcms.2025.07.009","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:22:51Z","timestamp":1754407371000},"page":"1738-1746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progression-, aggression-, survival and outcome characteristics in Merkel cell carcinomas in 176 patients"],"prefix":"10.1016","volume":"53","author":[{"given":"M.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Depping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hallermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Raguse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"H\u00f6lzle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wermker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jcms.2025.07.009_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jamadermatol.2013.8116","article-title":"Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with merkel cell carcinoma","volume":"150","author":"Asgari","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.jcms.2025.07.009_bib2","first-page":"562","article-title":"S2k\u2010Leitlinie Merkelzellkarzinom (MZK, MCC, Neuroendokrines Karzinom Der Haut) \u2013 update 2018","volume":"17","author":"Becker","year":"2019","journal-title":"JDDG J. der Deutschen Dermatol. Gesellschaft"},{"issue":"1","key":"10.1016\/j.jcms.2025.07.009_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.jcms.2025.07.009_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-15-0059","article-title":"Antibody-dependent cellular cytotoxicity activity of a novel Anti\u2013PD-L1 antibody avelumab (MSB0010718C) on human tumor cells","volume":"3","author":"Boyerinas","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.jcms.2025.07.009_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/cancers16030587","article-title":"New tumor budding evaluation in head and neck squamous cell carcinomas","volume":"16","author":"Cacchi","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jcms.2025.07.009_bib6","doi-asserted-by":"crossref","first-page":"dju382","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.jcms.2025.07.009_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa1506007","article-title":"Elective versus therapeutic neck dissection in node-negative oral cancer","volume":"373","author":"D'Cruz","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcms.2025.07.009_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.14352","article-title":"And the GEKID cancer survival working group, survival with nonmelanoma skin cancer in Germany","volume":"174","author":"Eisemann","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"9305","key":"10.1016\/j.jcms.2025.07.009_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection","volume":"359","author":"Engels","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jcms.2025.07.009_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jdv.14798","article-title":"Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey","volume":"32","author":"Fondain","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"5","key":"10.1016\/j.jcms.2025.07.009_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2011.10493.x","article-title":"Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival","volume":"165","author":"Girschik","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.jcms.2025.07.009_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1940-6207.CAPR-12-0185-T","article-title":"Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis","volume":"5","author":"Han","year":"2012","journal-title":"Cancer Prev. Res."},{"issue":"11","key":"10.1016\/j.jcms.2025.07.009_bib13","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann. Surg Oncol."},{"issue":"8","key":"10.1016\/j.jcms.2025.07.009_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","article-title":"Merkel cell carcinoma and multiple primary cancers","volume":"15","author":"Howard","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev.: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"4","key":"10.1016\/j.jcms.2025.07.009_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jcms.2025.07.009_bib16","first-page":"835","article-title":"Sentinel node status and immunosuppression: recurrence factors in localized merkel cell carcinoma","volume":"95","author":"Jouary","year":"2014","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.jcms.2025.07.009_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","article-title":"Updated efficacy of avelumab in patients with previously treated metastatic merkel cell carcinoma after \u22651 year of follow-up: JAVELIN merkel 200, a phase 2 clinical trial","volume":"6","author":"Kaufman","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.jcms.2025.07.009_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2017.12.029","article-title":"Merkel cell carcinomas infiltrated with CD33 + myeloid cells and CD8 + T cells are associated with improved outcome","volume":"78","author":"Kervarrec","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jcms.2025.07.009_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.31860","article-title":"Epidemiology of merkel cell carcinoma. A population\u2010based study from 1985 to 2013, in northeastern of France","volume":"144","author":"Kieny","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.jcms.2025.07.009_bib20","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.3390\/cancers15164087","article-title":"IMP3 expression as a potential tumour marker in high-risk localisations of cutaneous squamous cell carcinoma: IMP3 in metastatic cSCC","volume":"15","author":"Klein","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jcms.2025.07.009_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.oooo.2023.12.795","article-title":"A potential new biomarker in HNSCC: metastasis suppressor protein 1 (MTSS1)","volume":"137","author":"Klein","year":"2024","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"5","key":"10.1016\/j.jcms.2025.07.009_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102977","article-title":"Merkel-cell carcinoma: ESMO\u2013EURACAN clinical practice guideline for diagnosis, treatment and Follow-Up","volume":"9","author":"Lugowska","year":"2024","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.jcms.2025.07.009_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/apc.2006.0152","article-title":"Merkel cell carcinoma and HIV infection: a case report and review of the literature","volume":"21","author":"Manganoni","year":"2007","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"10.1016\/j.jcms.2025.07.009_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/php.12318","article-title":"Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response","volume":"91","author":"Ming","year":"2015","journal-title":"Photochem. Photobiol."},{"issue":"6","key":"10.1016\/j.jcms.2025.07.009_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/bjd\/ljad404","article-title":"Incidence, mortality and survival of merkel cell carcinoma: a systematic review of population-based studies","volume":"190","author":"Mohsen","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"5742","key":"10.1016\/j.jcms.2025.07.009_bib26","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"O'Donovan","year":"2005","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.jcms.2025.07.009_bib27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2010.30.6308","article-title":"Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival","volume":"29","author":"Paulson","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jcms.2025.07.009_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","article-title":"Epidemiology and survival of merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007","volume":"47","author":"Reichgelt","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcms.2025.07.009_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.02.003","article-title":"The association between geographic location and incidence of merkel cell carcinoma in comparison to melanoma: an international assessment","volume":"94","author":"Stang","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.jcms.2025.07.009_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2012.09.036","article-title":"Prognostic factors in merkel cell carcinoma: analysis of 240 cases","volume":"68","author":"Tarantola","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jcms.2025.07.009_bib31","series-title":"Annual Meeting","first-page":"e519","article-title":"Merkel cell carcinoma: emerging biology, current approaches, and future directions, American society of clinical oncology educational book","author":"Tothill","year":"2015"},{"issue":"8","key":"10.1016\/j.jcms.2025.07.009_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"10","key":"10.1016\/j.jcms.2025.07.009_bib33","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/jdv.13698","article-title":"Merkel cell carcinoma incidence is increasing in Sweden","volume":"30","author":"Zaar","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jcms.2025.07.009_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers15010103","article-title":"Merkel cell carcinoma-update on diagnosis, management and future perspectives","volume":"15","author":"Zaggana","year":"2022","journal-title":"Cancers"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101051822500232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101051822500232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:01:19Z","timestamp":1757509279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S101051822500232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S101051822500232X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2025.07.009","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression-, aggression-, survival and outcome characteristics in Merkel cell carcinomas in 176 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2025.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Association for Cranio-Maxillo-Facial Surgery.","name":"copyright","label":"Copyright"}]}}